Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11576934 Methods and compositions for immunomodulation

Patent 11576934 was granted and assigned to Rubius Therapeutics on February, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Rubius Therapeutics

Current Assignee

Rubius Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11576934

Date of Patent

February 14, 2023

Patent Application Number

16383236

Date Filed

April 12, 2019

Patent Citations

‌

US Patent 10344263 Synthetic membrane-receiver complexes

‌

US Patent 10456421 Compositions and methods related to engineered erythoid cells comprising 4-1BBL

‌

US Patent 10471099 In vitro production of red blood cells with proteins comprising sortase recognition motifs

‌

US Patent 10517897 Methods related to engineered erythoid cells comprising 4-1BBL

‌

US Patent 10557119 Erythroid cells comprising phenylalanine ammonia lyase

‌

US Patent 10869898 Methods and compositions for immunomodulation

‌

US Patent 10568910 Compositions and methods related to engineered erythroid cells comprising IL-15

‌

US Patent 10253296 Synthetic membrane-receiver complexes

...

Patent Primary Examiner

‌

Maria Marvich

Provided are cells containing exogenous antigen and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11576934 Methods and compositions for immunomodulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API